Laponis Adam 4
4 · Twist Bioscience Corp · Filed Oct 10, 2025
Insider Transaction Report
Form 4
Laponis Adam
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-08$31.15/sh−3,000$93,450→ 94,042 total - Sale
Common Stock
2025-10-09$32.92/sh−2,517$82,865→ 91,525 total
Footnotes (2)
- [F1]The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.